Purchase Order 75D30123P17414
Award Date 8/17/23
Potential Completion Date 8/31/24
Potential Value $179K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irvine, CA 92618, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Immport Therapeutics Inc., doing business as Antigen Discovery Inc., for $30,000.00. The contract is for the provision of microarray products and services to support detection and response efforts related to pathogens such as monkeypox virus, Brucella, SARS-CoV-2, and Leptospirosis. Immport Therapeutics is a biotechnology company specializing in high throughput...
- This SBIR Phase I contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $150,000.00 firm fixed price purchase order is for the company's high throughput protein microarray technology and related services. Immport Therapeutics has provided these products and services to support the CDC's detection and response efforts for pathogens such as monkeypox virus, Brucella,...
- This is a $300,000.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for SBIR 133 - ANTIGEN and has an ultimate completion date of September 9, 2025. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and related services to support infectious disease detection, monitoring, and research....
- The Centers for Disease Control and Prevention (CDC) awarded a $200,000.00 firm fixed price purchase order to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc., a biotechnology company specializing in protein microarray technology. The contract is for the identification of Brucella canis and B. abortus RB51 seroreactive proteins and the development of serology assays. This sole-source contract was awarded without a set-aside designation. Antigen Discovery has extensive...
- This federal contract award was issued by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $110,458.00 firm fixed price purchase order is for ADI Leptospirosis work, with a performance period ending August 18, 2020. Antigen Discovery is a biotechnology company that provides microarray products and services to support the CDC's disease detection and response efforts, including...
- This is a $5,680 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract is for the analysis of protein samples, which supports NIAID's mission in infectious disease research and response. Immport Therapeutics is a biotechnology company that specializes in protein microarray technology and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Immport Therapeutics Inc., doing business as Antigen Discovery Inc. The contract, valued at $15,000.00, is for the provision of falciparum custom protein microarrays. Immport Therapeutics is a biotechnology company that specializes in high-throughput protein microarray technology and related services, and has...
- This is a federal contract award to Altona Diagnostics USA Inc., a foreign-owned, for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian agency. The contract is for the delivery of MPOX (monkeypox) detection kits, with a ceiling value of $94,926.42. The contract is structured as a firm fixed-price purchase order, without any set-aside designation. This award is the latest in a series of contracts between Altona Diagnostics USA Inc. and the...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Miscellaneous Foreign Awardees, a for-profit organization registered in the System for Award Management (SAM). The contract, valued at $58,300.00, is for the procurement of emergency laboratory commodities to support the monkeypox (MPOX) outbreak. The contract is a firm fixed-price purchase order with a period of performance ending on July 31, 2025. Miscellaneous Foreign Awardees is a subsidiary of...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a firm-fixed-price purchase order to Altona Diagnostics USA Inc., a foreign-owned, for-profit organization, for the delivery of MPOX (monkeypox) detection kits. The contract, which does not have a set-aside designation, is valued at $59,938.76 and has a completion date of April 19, 2024. Altona Diagnostics USA Inc. is a company that develops and manufactures in vitro...